Antioxidative effects of proteoglycans of embryonic genesis in streptozotocin-induced diabetic rats
Vahid Vahedian,1 Yelena M Aghajanova,2 Gevorg A Kevorkian,3 Maxim A Simonyan3
1Department of Biochemistry, 2Department of Endocrinology, Yerevan State Medical University after M Heratsi, Yerevan, Armenia, 3Buniatyan Institute of Biochemistry, National Academy of Science, Yerevan, Armenia
Introduction: It is well accepted that oxidative stress plays a significant role in the pathogenesis of diabetes mellitus. The objective of this study was to investigate the effect of proteoglycans of embryonic genesis (PEG) on concentrations and activity of prooxidative and antioxidative metalloproteins in streptozotocin (STZ)-induced diabetes in rats.
Methods: Study groups were as follows: vehicle control group (Group 1), STZ-induced diabetes (55 mg/kg, intraperitoneal injection [Group 2]), STZ-induced diabetes with prophylactic injection of PEG (0.5 mg/kg intraperitonealy injected) 1 week prior to STZ injection (Group 3). The following prooxidative metalloproteins were studied: levels of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox) isoforms (extracellular Nox [eNox]) in serum; erythrocyte membranes; and spleen cell membranes, nucleus and mitochondria, as well as serum levels of superoxide-producing lipoprotein (suprol); cytochrome (cyt) b5 from cytosol of erythrocytes; and cyt c from spleen cell cytosol. The antioxidative metalloproteins, particularly superoxide dismutase and catalase from erythrocyte and from spleen cell cytosol were studied.
Results: Results demonstrated the significant (P < 0.05) increase in the level and activity of NADPH-dependent, O2--producing eNox activity in Group 2 in comparison with the control Group and decrease of the ferrihemoglobin-reducing activities of these Nox, as well as a significant increase in O2--producing activity of suprol. In Group 2, there was a significant elevation of the level of cyt c, and decreased cyt b5 level, as well as inhibition of superoxide dismutase and catalase activity.
Conclusion: The prophylactic injection of the PEG demonstrated overall antioxidative effect, with prevention of changes in prooxidative markers.
Keywords: proteoglycans of embryonal genesis (PEG), streptozotocin-induced diabetes, antioxidant, prevention
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]